nach oben

Current Diabetes Reports

Erschienen in:

01.12.2020 | Hospital Management of Diabetes (A Wallia and J Seley, Section Editors)

Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control

verfasst von: Preethika S. Ekanayake, Patricia S. Juang, Kristen Kulasa

Erschienen in: Current Diabetes Reports | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The goal of this review is to summarize current literature on electronic glucose management systems (eGMS) and discuss their benefits and disadvantages in the inpatient setting.

Recent Findings

We review different versions of commercially available eGMS: Glucommander™ (Glytec, Greenville, SC), EndoTool^R (MD Scientific LLC, Charlotte, NC), GlucoStabilizer™ (Medical Decision Network, Charlottesville, VA), GlucoCare™ (Pronia Medical Systems, KY), and discuss advantages such as reducing rates of hypoglycemia, hyperglycemia, and glycemic variability. In addition, eCGMs offer a uniform standard of care and may improve workflows across institutions as well reduce barriers.

Summary

Despite ample literature on intravenous (IV) versions of eGMS, there is little published research on subcutaneous (SQ) insulin guidance. Although use of eGMS requires extensive training and institution-wide adoption, time spent on diabetes management is better facilitated by their use.

American Diabetes Association. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes 2020. Diabetes Care. 2020;43:S193–202.

Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.PubMed

Van den Bergh G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.

NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–18.

Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10):2262–7.PubMed

Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461–7.PubMed

Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C, et al. Impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13(3):R91.PubMedPubMedCentral

Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244–52.PubMed

White NH, Skor D, Santiago JV. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med. 1982;97(2):210–3.PubMed

10.

Davidson PC, Steed RD, Bode BW. Glucommander: a computer directed insulin system shown to be safe, simple and effective in 120,618 h of operation. Diabetes Care. 2005;28(10):2418–23.PubMed

11.

Newton CA, Smiley D, Bode BW, Kitabchi AE, Davidson PC, Jacobs S, et al. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column based algorithms. J Hosp Med. 2010;5(8):432–7.PubMedPubMedCentral

12.

Rabinovich M, Grahl J, Durr E, Gayed R, Chester K, McFarland R, et al. Risk of hypoglycemia during insulin infusion directed by paper protocol versus electronic glycemic management system in critically ill patients at a large academic medical center. J Diabetes Sci Technol. 2018;12(1):47–52.PubMed

13.

Ullal J, McFarland R, Bachand M, Aloi J. Use of a computer-based insulin infusion algorithm to treat diabetic ketoacidosis in the emergency department. Diabetes Technol Ther. 2016;18(2):100–3.PubMed

14.

Ullal J, Aloi JA, Reyes-Umpierrez D, Pasquel FJ, McFarland R, Rabinovich M, et al. Comparison of computer-guided versus standard insulin infusion regimens in patients with diabetic ketoacidosis. J Diabetes Sci Technol. 2018;12(1):39–46.PubMedPubMedCentral

15.

Desai D, Mehta D, Mathiyas P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care. 2018;41(8):1631–8.PubMed

16.

Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38:1665–72.PubMedPubMedCentral

17.

Cardona S, Pasquel FJ, Fayfman M, Peng L, Jacobs S, Vellanki P, et al. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. J Diabetes Complicat. 2017;31(4):742–7.

18.

“Diabetes facts and figures.” International Diabetes Federation 2020 [Cited May 3, 2020]. Available from https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html

19.

Hammer MJ, Casper C, Gooley TA, O’Donnell PV, Boeckh M, Hirsch IB. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2009;15(3):344–51.PubMedPubMedCentral

20.

Gebremedhin E, Behrendt CE, Nakamura R, Parker P, Salehian B. Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease. Inflammation. 2013;36(1):177–85.PubMedPubMedCentral

21.

Espina C, Jenkins I, Taylor L, Farah R, Cho E, Epworth J, et al. Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant. 2016;51(7):973–9.PubMed

22.

Phillips VL, Byrd AL, Adeel S, Peng L, Smiley DD, Umpierrez GE. A comparison of inpatient cost per day in general surgery patients with type 2 diabetes treated with basal-bolus versus sliding scale insulin regimens. Pharmacoecon Open. 2017;1(2):109–15.PubMedPubMedCentral

23.

Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2017;11(1):12–6.PubMed

24.

• Newsom R, Patty C, Camarena E, Sawyer R, McFarland R, Gray T, et al. Safely converting an entire academic medical center from sliding scale to basal bolus insulin via implementation of the eglycemic management system. J Diabetes Sci Technol. 2018;12(1):53–9 This study showed that the eGMS SQ version improved hyper and hypoglycemia, time in range, and reduction in length of stay, and demonstrated best practices for ordering appropriate basal/bolus insulin.PubMed

25.

Mann EA, Jones JA, Wolf SE, Wade CE. Computer decision support software safely improves glycemic control in the burn intensive care unit: a randomized controlled clinical study. J Burn Care Res. 2011;32(2):246–55.PubMedPubMedCentral

26.

Fogel SL, Baker CC. Effects of computerized decision support systems on blood glucose regulation in critically ill surgical patients. J Aml Coll Surg. 2013;216(4):828–33.

27.

John SM, Waters KL, Jivani K. Evaluating the implementation of the EndoTool glycemic control software system. Diabetes Spectr. 2018;31(1):26–30.PubMedPubMedCentral

28.

• Tanenberg RJ, Hardee S, Rothermel C, Drake AJ. Use of computer-guided glucose management system to improve glycemic control and address national quality measures: a 7-year, retrospective observational study at a tertiary care teaching hospital. Endocr Pract. 2017;23(3):331–41 This study showed marked improvement in quality of care with eGMS, leading to reduced hypoglycemia year by year despite doubling the volume of enrolled patients, rapid time to BG control, low glucose excursions, and low glycemic variability.PubMed

29.

Magee M. Improving IV insulin administration in a community hospital. J Vis Exp. 2012;64:1–8.

30.

Dumont C, Bourguignon C. Effect of a computerized insulin dose calculator on the process of glycemic control. Am J Crit Care. 2012;21(2):106–15.PubMed

31.

Juneja R, Roudebush C, Kumar N, Macy A, Golas A, Wall D, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232–40.PubMed

32.

Juneja R, Roudebush CP, Nasraway SA, Golas AA, Jacobi J, Carroll J, et al. Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. Crit Care. 2009;13(R163):1–10.

33.

Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933–44.PubMed

34.

Saur NM, Kongable GL, Holewinski S, O’Brien K, Nasraway SA. Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients. Mayo Clin Proc. 2013;88(9):920–9.PubMed

35.

Dinglas C, Muscat J, Adams T, Peragallo-Dittko V, Vintzileos A, Heo HJ. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus. Am J Obstet Gynecol. 2018;219(2):191.e1–6.

36.

Gestational Diabetes Mellitus Practice Bulletin 190. American College of Obstetricians and Gynecologists 2018 [cited May 3, 2020]. Available from https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/02/gestational-diabetes-mellitus

37.

Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic strok: the SHINE randomized clinical trial. JAMA. 2019;322(4):326–35.PubMedPubMedCentral

38.

Juneja R, Golas AA, Caroll J, Nelson D, Abad VJ, Roudebush CP, et al. Safety and effectiveness of a computerized subcutaneous insulin program to treat inpatient hyperglycemia. J Diabetes Sci Technol. 2008;2(3):384–91.PubMedPubMedCentral

39.

40.

Marvin MR, Inzucchi SE, Besterman BJ. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. Diabetes Technol Ther. 2013;15(3):246–52.PubMedPubMedCentral

41.

Marvin MR, Inzucchi SE, Besterman BJ. Minimization of hypoglycemia as an adverse event during insulin infusion: further refinement of the Yale protocol. Diabetes Technol Ther. 2016;18(8):480–6.PubMedPubMedCentral

42.

Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251–76.PubMed

43.

Kulasa K. Computer guided insulin dosing. Presented at Diabetes Technology Society Virtual Hospital Diabetes Meeting, 2020.

44.

Ullal J, Aloi JA. Subcutaneous insulin dosing calculators for inpatient glucose control. Curr Diab Rep. 2019;19(11):120.PubMed

45.

Maynard G, Kulasa K, Ramos P, Childers D, Clay B, Sebasky M, et al. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract. 2015;21(4):355–67.PubMed

Titel: Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control
verfasst von: Preethika S. Ekanayake
Patricia S. Juang
Kristen Kulasa
Publikationsdatum: 01.12.2020
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 12/2020
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-020-01364-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

15.04.2024 | Inkretinmimetika | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Fast jeder zehnte Magen bei Endoskopie noch nicht entleert

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Blutdrucksenkung per Spritze additiv zur Standardtherapie wirksam

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes

Does Weight Loss Improve Clinical Outcomes in Overweight and Obese Patients with Heart Failure?

Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad

Sleep Extension: A Potential Target for Obesity Treatment

Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps

Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Fast jeder zehnte Magen bei Endoskopie noch nicht entleert

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Blutdrucksenkung per Spritze additiv zur Standardtherapie wirksam

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Innere Medizin